Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Dezhan Healthcare Yönetim

Yönetim kriter kontrolleri 2/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Wei Liu

İcra Kurulu Başkanı

CN¥4.0m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	8yrs
CEO sahipliği	0.2%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	3.2yrs

Son yönetim güncellemeleri

Recent updates

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Apr 18

CEO

Wei Liu (54 yo)

8yrs

Görev süresi

CN¥3,980,000

Tazminat

Mr. Wei Liu is Co-Chairman & GM of Dezhan Healthcare Company Limited from October 28, 2016.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Wei Liu	Co-Chairman & GM	8yrs	CN¥3.98m	0.23% CN¥ 15.0m
Weihong Sun	Independent Director	3.2yrs	CN¥180.00k	Veri yok
Bin Wu	Independent Director	3.2yrs	CN¥180.00k	Veri yok
Hailin Yan	Non-Independent Director	3.2yrs	Veri yok	Veri yok
Zheming Wei	Chairman	8yrs	Veri yok	0.021% CN¥ 1.4m
Feng Han	Director	2.4yrs	Veri yok	Veri yok
Sinian Chou	Non-Independent Director	3.2yrs	CN¥60.00k	Veri yok
Xin An Wang	Independent Director	3.2yrs	CN¥180.00k	Veri yok
Ping Liu	Supervisor	less than a year	Veri yok	Veri yok

3.2yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 000813's board of directors are considered experienced (3.2 years average tenure).

Dezhan Healthcare Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

High number of new and inexperienced directors

Recent updates

Dezhan Healthcare Company Limited to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 24%

Dezhan Healthcare Company Limited (SZSE:000813) announces an Equity Buyback for CNY 300 million worth of its shares.

Second quarter 2024 earnings released: EPS: CN¥0.012 (vs CN¥0.004 loss in 2Q 2023)

Dezhan Healthcare Company Limited to Report First Half, 2024 Results on Aug 28, 2024

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Full year 2023 earnings released: EPS: CN¥0.038 (vs CN¥0.021 loss in FY 2022)

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

Dezhan Healthcare Company Limited to Report Q1, 2024 Results on Apr 25, 2024

Dezhan Healthcare Company Limited to Report Fiscal Year 2023 Results on Apr 12, 2024

Third quarter 2023 earnings released: EPS: CN¥0.033 (vs CN¥0 in 3Q 2022)

Dezhan Healthcare Company Limited to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.016 profit in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.014 in 1Q 2022)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0 (vs CN¥0.01 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.016 (vs CN¥0.017 in 2Q 2021)

Full year 2021 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.01 (vs CN¥0.026 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.017 (vs CN¥0.041 in 2Q 2020)

Dezhan Healthcare Company Limited Approves Final Dividend Implementation Plan (A Shares) for 2020, Payable on June 1, 2021

Dezhan Healthcare Company Limited Announces the Profit Distribution Proposal for 2020

First quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.041 in 1Q 2020)

Investor sentiment improved over the past week

New 90-day low: CN¥3.98

Investor sentiment deteriorated over the past week

New 90-day low: CN¥5.85

Dezhan Healthcare's Controlling Shareholder Plans to Sell Stake in the Company

New 90-day high: CN¥6.85

Third quarter earnings released

New 90-day low: CN¥6.05

First half earnings released

Dezhan Healthcare Company Limited to Report First Half, 2020 Results on Aug 29, 2020

Dezhan Healthcare Company Limited (SZSE:000813) completed the acquisition of 70% stake in Beijing Changjiang Mai Medical Technology Co., Ltd from Dai Yanzhen.

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş